|
||
ARTICLE |
CORRESPONDENCE Yang Liu: yang.liu{at}osumc.edu
|
|
|---|
O. Li and X. Chang contributed equally to this paper.
X. Chang's, H. Zhang's, C. Ding's, P. Zheng's, and Y. Liu's present address is Division of Immunotherapy, Department of Surgery, University of Michigan Medical Center, Ann Arbor, MI 48109.
The immune system uses multiple mechanisms to maintain a relatively constant number of lymphocytes. The expansion of antigen-specific lymphocytes during the immune response to infection results in a large increase in the cellularity of the secondary lymphoid organ (1, 2), which is normally followed by activation-induced cell death (3, 4). On the other hand, T lymphocytes spontaneously divide when the hosts are lymphopenic (57). Lymphopenia is found in newborn animals (8) and in those exposed to chemotherapy (9) or irradiation (57). Because the latter event is viewed as the host attempts to restore the lymphocyte cellularity, it is often referred to as homeostatic proliferation.
Homeostatic proliferation is similar to antigen-driven proliferation in its requirement for MHCTCR interaction (5, 10). However, these two types of T cell proliferation differ in several important ways. First, homeostatic proliferation is polyclonal and results in the preservation of the TCR repertoire (1113), whereas antigen-driven proliferation results in the clonal expansion of T cells that are specific for the antigens involved (1, 2). Second, homeostatic proliferation and antigen-driven proliferation use distinct costimulatory pathways. For instance, although B7CD28 interaction has a major impact on antigen-driven proliferation (1416), it is dispensable for homeostatic proliferation (17). Likewise, CD40CD40L and 4-1BB4-1BBL interactions are also not required for homeostatic proliferation (17). On the other hand, we have recently reported that CD24 expression on T cells is essential for homeostatic proliferation (18), although the targeted mutation of CD24 did not impair T cell priming in the lymphoid organ (19, 20). Third, homeostatic proliferation of naive T cells requires IL-7, whereas priming of antigen-specific T cells is IL-7 independent (21, 22).
Given the abundance of MHCpeptide ligands that can trigger both positive selection and homeostatic proliferation, it is of great interest to understand how homeostatic proliferation is slow paced and appears self-limiting. In theory, this can be explained on the basis of a weak activation signal and/or active inhibitory signal. In this study, we report a serendipitous observation that in the lymphopenic CD24-deficient host, the T cells undergo massive homeostatic proliferation, leading to the rapid death of the recipients. The uncontrolled proliferation is caused by the superior stimulatory activity of DCs generated from the CD24-deficient mice. Our results reveal a vital inhibitory checkpoint that controls the pace of homeostatic proliferation.
| RESULTS |
|---|
|
|
|---|
|
As an alternative approach, we adoptively transferred CFSE-labeled T cells from Thy1.1 congenic mice into either C57BL/6 or C57BL/6 CD24/ mice. 4 d later, the recipient mice were killed, and proliferation of the donor cells was analyzed by flow cytometry. As shown in Fig. 1 d, the donor cells underwent no proliferation over the 4-d period. These results demonstrate that in the absence of lymphopenic cue, CD24 deficiency in the host cells was unable to induce the proliferation of T cells from congenic mice.
Our extensive analyses have demonstrated that CD24 deficiency does not substantially impact the priming of T cells (19, 20, 24). To test whether CD24 deficiency in the host cells specifically affects homeostatic proliferation, we labeled OT-1 T cells with CFSE and injected them into the host that had been immunized with the specific ovalbumin peptide. As shown in Fig. 2 , essentially identical proliferation was observed in the WT and CD24-deficient mice. Again, the OT-1 cells did not proliferate in unimmunized mice. Collectively, our data demonstrate that CD24 deficiency in the host selectively enhanced homeostatic T cell proliferation. Therefore, CD24 on the APC served as a suppressor of homeostatic T cell proliferation.
|
|
|
To confirm that CD24 deficiency is sufficient to confer superior homeostatic proliferation in vivo, we adoptively transferred naive T cells together with WT and CD24/ DCs into lymphopenic WT hosts and monitored T cell proliferation 4 d later. As shown in Fig. 4 f, the injection of CD24/ but not WT DCs led to the strong homeostatic proliferation of T cells. Collectively, our data demonstrate that CD24 expressed on DCs controls the pace of homeostatic proliferation in lymphopenic hosts.
Fatal destruction of the CD24-deficient host associated with mass T cell proliferation
Surprisingly,
60% of the CD24/ recipients died within 2 wk after T cell transfer, whereas all of the WT recipients remained healthy (Fig. 5
). The death was caused by adoptively transferred T cells, as the control mice that received no T cells were healthy. We have systematically examined the host for histological signs of acute graft versus host diseases. As shown in Fig. S3 (available at http://www.jem.org/cgi/content/full/jem.20052293/DC1), no inflammation was observed in the gut or other organs of the CD24-deficient host. Thus, the destruction of the recipient is pathologically distinct from graft versus host diseases. Histology of the spleen suggests extensive hemolysis in the red blood cells in the moribund mice (unpublished data). The high fatality and rapid onset demonstrate the vital role of CD24-mediated regulation of homeostatic proliferation.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Our data demonstrate that WT T cells adoptively transferred into CD24-deficient mice underwent massive homeostatic proliferation that ultimately led to the death of the majority of the recipients. The death was associated with massive T cell activation but not infiltrations of organs, which is inconsistent with the activation of organ-specific T cells. Although this may be associated with so-called "cytokine storm," our analysis did not reveal an obvious rise in the percentage of T cells capable of producing TNF-
, a cytokine frequently associated with cytokine storm (Fig. S4, available at http://www.jem.org/cgi/content/full/jem.20052293/DC1). Therefore, the death was unlikely caused by excessive TNF production. Histological analysis of the spleen revealed extensive hemosiderin deposits in red pulps, which is indicative of hemolysis in moribund mice (unpublished data), although its cause and significance remains to be determined.
In addition to the adoptive transfer model, we also observed a substantially increased homeostatic proliferation in CD24-deficient mice after CD4 and CD8 T cells were deleted by a single injection of a low dose of anti-CD4 + anti-CD8 antibodies. These results are noteworthy for three reasons. First, because this assay involved no adoptive transfer, it helped to further rule out the possibility that increased proliferation was caused by histoincompatibility between donor and recipient cells even though the CD24-deficient mice were produced in embryonic stem cells derived from C57BL/6 mice. Second, because the hosts were not irradiated, the increased proliferation was not associated with changes in the irradiated recipient. Third, although CD24 expression in T cells was essential for optimal homeostatic proliferation in the WT host, such a requirement can be bypassed by a lack of CD24 on host APCs. Thus, negative regulation mediated by CD24 on APCs plays a dominant role over the positive regulatory role for CD24 on T cells.
We have presented several lines of evidence that the lack of CD24 in the DCs explains the massive homeostatic proliferation. Thus, the CD24-mediated suppression of homeostatic proliferation is mediated by bone marrowderived cells as the reconstitution of CD24/ mice with the CD24+/+ bone marrow restored the pace of homeostatic proliferation. In an in vitro model of homeostatic proliferation, DCs from CD24/ mice were more potent in inducing the proliferation of syngeneic T cells, whereas B cells and macrophages were unable to induce homeostatic proliferation. Most importantly, the adoptive transfer of bone marrowderived DCs from CD24/ mice led to massive homeostatic proliferation in the lymphopenic WT host. Thus, defective CD24 expression on DCs plays a dominant role in driving massive homeostatic proliferation.
We have demonstrated that a targeted mutation of CD24 exacerbated immune deficiency associated with the targeted mutation of CD28 (19, 20), which revealed CD24 as a redundant costimulatory molecule for antigen-driven proliferation. In contrast, CD24/ DCs have a drastically stronger activity in inducing homeostatic proliferation. The apparently opposite function of CD24 in the two processes highlights the distinct requirements of T cell response to antigen and homeostatic cue. In this context, it is worth noting that anti-CD24 antibody 20C9, which blocks the costimulatory function of CD24, has no effect on the DC-mediated costimulatory function (unpublished data). It is likely that distinct structures on CD24 are involved in T cell costimulation and in homeostatic proliferation.
CD24 is a highly glycosylated cell surface molecule that is anchored through a glycosylphosphatidylinositol tail. Mouse CD24 consists of 27 amino acids that include eight potential O-linked glycosylation sites and three potential N-linked glycosylation sites (30). The heterogeneity of CD24, which is presumably caused by differential glycosylation, has made it difficult to identify the counter receptor involved in pacing homeostatic proliferation. In spite of this, our work provides the first evidence that the pace of T cell homeostatic proliferation is actively maintained by CD24 expressed on host APCs to avoid deleterious consequences associated with the uncontrolled polyclonal activation of T cells.
| MATERIALS AND METHODS |
|---|
|
|
|---|
All conjugated antibodies used were purchased from either eBioscience (Thy1.1, CD80, CD86, CD44, and CD62L) or BD Biosciences (CD4, CD8, H-2Kb, I-Ab, CD25, CD40, Annexin V, IFN-
, TNF-
, and isotype control).
Analysis of T cell division in vivo.
T lymphocytes were purified from pooled spleen and lymph node cells by negative selection. In brief, pools of spleen and lymph node cells were incubated with a cocktail of antibodies specific for CD11b (Mac-1), Fc receptor (2.4G2), B220, and CD11c. The Dynal beads coated with goat antirat IgG were used to negatively select T cells. The purity of the cells was checked by flow cytometry to be >95%. The purified T cells congenic in the Thy1 locus (B6 and Thy1.1+) were labeled with CFSE and injected intravenously into irradiated (600 R) recipient mice that were WT or CD24/ (B6 and Thy1.2+) at a dose of 5 x 106/mouse. At given times after adoptive transfer, spleen cells were harvested and analyzed for the intensity of CFSE dye and other cell surface markers.
Bone marrow reconstitution.
Bone marrow cells from WT B6 mice and CD24/ mice were transferred back to 1,000 radirradiated CD24/ mice. 4 wk later, CD24 expression was detected in both groups to determine the reconstitution efficiency.
DCs cultured from bone marrow.
Bone marrow cells from WT B6 mice or CD24/ mice were cultured with 10% RPMI and recombinant mouse GM-CSF as described previously (31). LPS was added into the culture after day 10 at a final concentration of 1 µg/ml for 2 d. The nonadherent cells harvested from the culture were mature DCs.
T cellDC coculture.
For suspension cultures, CFSE-labeled Thy1.1+ T cells (usually 500,000/well) were mixed with given numbers of matured DCs in 24-well plates in RPMI 1640 medium. Cells were cultured at 37° in a humidified 5% CO2 incubator for 5 d before analysis.
T cell depletion and recovery in vivo.
WT or CD24/ mice were injected with 100 µg anti-CD4 (GK1.5) and 100 µg anti-CD8 (2.4.3) antibody. The mice were bled, and percentages of CD4 and CD8 T cells in the peripheral blood were determined by flow cytometry. 7 d after the antibody injection, some of the mice were given three injections of BrdU (1 mg/injection i.p.) with 12-h intervals. 12 h after the last BrdU injection, spleen cells were analyzed for division by BrdU incorporation and cell death by Annexin V staining.
Flow cytometry.
The cell surface markers, including CD4, CD8, CD24, CD25, CD44, CD62L, and Thy1.1, were analyzed by three- or four-color flow cytometry using fluorochrome-conjugated monoclonal antibodies purchased from BD Biosciences. To assess intracellular cytokine production, spleens were harvested. The splenocytes were stimulated with PMA for 4 h and stained for cell surface markers CD4 and CD8 followed by intracellular staining for IFN-
/TNF-
and/or isotype control using the CytoFix/CytoPerm kit (BD Biosciences).
TREC assay for recent thymic emigrants.
Copy numbers of the sjTREC were used to determine the frequency of recent thymic emigrant (28). In brief, total DNA was purified from total splenocytes with the DNA Easy kit (QIAGEN). Real-time PCR was performed using the Quantitative PCR kit (Invitrogen). The primers used were as follows: m
Rec primer (5'-GGGCACACAGCAGCTGTG-3'),
J
primer (5'-GCAGGTTTTTGTAAAGGTGCTCA-3'), m
Rec-
J
fluorescent probe (5'-FAM-CACAAGCACCTGCACCCTGTGCA-TAMRA-3'), and CD8ß forward primer (5'-CAGGACCCCAAGGACAAGTACT-3'), reverse primer (5'-CACTTTCACCATACAAAACTCCTTTG-3'), and probe (5'-FAM-TGAGTTCCTGGCCTCCTGGAGTTCTTC-TAMRA-3'). The number of TREC/million T cells was calculated by: 2 x (number of TREC/number of CD8ß x percentage of T cells) x 106.
Online supplemental material.
Fig. S1 shows that despite a major difference in the rate of homeostatic proliferation, the numbers of donor T cells were comparable in WT and CD24/ recipients. Fig. S2 shows that CD24 deficiency does not alter the expression of MHC and costimulatory molecules on DCs. Fig. S3 shows the histology analysis of healthy WT mice and moribund CD24-deficient mice. No inflammation was observed in the moribund mice. Fig. S4 shows the high and comparable percentages of TNF-
and IFN-
producing cells in WT and CD24/ recipients. Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20052293/DC1.
| Acknowledgments |
|---|
This study was supported by grants from the National Institutes of Health and by the State of Ohio Biomedical Research Technology Transfer Grant.
The authors have no conflicting financial interests.
Submitted: 16 November 2005
Accepted: 19 May 2006
| References |
|---|
|
|
|---|
1 Butz, E.A., and M.J. Bevan. 1998. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity. 8:167175.[CrossRef][Medline]
2 Murali-Krishna, K., J.D. Altman, M. Suresh, D.J. Sourdive, A.J. Zajac, J.D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 8:177187.[CrossRef][Medline]
3 Wang, X.Z., S.E. Stepp, M.A. Brehm, H.D. Chen, L.K. Selin, and R.M. Welsh. 2003. Virus-specific CD8 T cells in peripheral tissues are more resistant to apoptosis than those in lymphoid organs. Immunity. 18:631642.[CrossRef][Medline]
4 Lohman, B.L., and R.M. Welsh. 1998. Apoptotic regulation of T cells and absence of immune deficiency in virus-infected gamma interferon receptor knockout mice. J. Virol. 72:78157821.
5 Goldrath, A.W., and M.J. Bevan. 1999. Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity. 11:183190.[CrossRef][Medline]
6 Goldrath, A.W., L.Y. Bogatzki, and M.J. Bevan. 2000. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J. Exp. Med. 192:557564.
7 Cho, B.K., V.P. Rao, Q. Ge, H.N. Eisen, and J. Chen. 2000. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J. Exp. Med. 192:549556.
8 Min, B., R. McHugh, G.D. Sempowski, C. Mackall, G. Foucras, and W.E. Paul. 2003. Neonates support lymphopenia-induced proliferation. Immunity. 18:131140.[CrossRef][Medline]
9 Dudley, M.E., J.R. Wunderlich, P.F. Robbins, J.C. Yang, P. Hwu, D.J. Schwartzentruber, S.L. Topalian, R. Sherry, N.P. Restifo, A.M. Hubicki, et al. 2002. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science. 298:850854.
10 Ernst, B., D.S. Lee, J.M. Chang, J. Sprent, and C.D. Surh. 1999. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity. 11:173181.[CrossRef][Medline]
11 Min, B., G. Foucras, M. Meier-Schellersheim, and W.E. Paul. 2004. Spontaneous proliferation, a response of naive CD4 T cells determined by the diversity of the memory cell repertoire. Proc. Natl. Acad. Sci. USA. 101:38743879.
12 Ge, Q., A. Bai, B. Jones, H.N. Eisen, and J. Chen. 2004. Competition for self-peptide-MHC complexes and cytokines between naive and memory CD8+ T cells expressing the same or different T cell receptors. Proc. Natl. Acad. Sci. USA. 101:30413046.
13 Schonland, S.O., J.K. Zimmer, C.M. Lopez-Benitez, T. Widmann, K.D. Ramin, J.J. Goronzy, and C.M. Weyand. 2003. Homeostatic control of T-cell generation in neonates. Blood. 102:14281434.
14 Kearney, E.R., T.L. Walunas, R.W. Karr, P.A. Morton, D.Y. Loh, J.A. Bluestone, and M.K. Jenkins. 1995. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155:10321036.[Abstract]
15 Bai, X.-F., J.-X. Gao, Q. Liu, J. Wen, P. Zheng, and Y. Liu. 2001. On the site and mode of antigen presentation for the initiation of clonal expansion of CD8 T cells specific for a natural tumor antigen. Cancer Res. 61:68606867.
16 Bai, X.F., J. Liu, K.F. May Jr., Y. Guo, P. Zheng, and Y. Liu. 2002. B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo. Blood. 99:28802889.
17 Prlic, M., B.R. Blazar, A. Khoruts, T. Zell, and S.C. Jameson. 2001. Homeostatic expansion occurs independently of costimulatory signals. J. Immunol. 167:56645668.
18 Li, O., P. Zheng, and Y. Liu. 2004. CD24 expression on T cells is required for optimal T cell proliferation in lymphopenic host. J. Exp. Med. 200:10831089.
19 Wu, Y., Q. Zhou, P. Zheng, and Y. Liu. 1998. CD28-independent induction of T helper cells and immunoglobulin class switches requires costimulation by the heat-stable antigen. J. Exp. Med. 187:11511156.
20 Liu, Y., R.H. Wenger, M. Zhao, and P.J. Nielsen. 1997. Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes. J. Exp. Med. 185:251262.
21 Schluns, K.S., W.C. Kieper, S.C. Jameson, and L. Lefrancois. 2000. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1:426432.[CrossRef][Medline]
22 Tan, J.T., E. Dudl, E. LeRoy, R. Murray, J. Sprent, K.I. Weinberg, and C.D. Surh. 2001. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA. 98:87328737.
23 Nielsen, P.J., B. Lorenz, A.M. Muller, R.H. Wenger, F. Brombacher, M. Simon, T. von der Weid, W.J. Langhorne, H. Mossmann, and G. Kohler. 1997. Altered erythrocytes and a leaky block in B-cell development in CD24/HSA-deficient mice. Blood. 89:10581067.
24 Bai, X.F., J.Q. Liu, X. Liu, Y. Guo, K. Cox, J. Wen, P. Zheng, and Y. Liu. 2000. The heat-stable antigen determines pathogenicity of self-reactive T cells in experimental autoimmune encephalomyelitis. J. Clin. Invest. 105:12271232.[Medline]
25 Surh, C.D., and J. Sprent. 2000. Homeostatic T cell proliferation: how far can T cells be activated to self-ligands? J. Exp. Med. 192:F9F14.
26 Bai, X.F., O. Li, Q. Zhou, H. Zhang, P.S. Joshi, X. Zheng, Y. Liu, Y. Wang, and P. Zheng. 2004. CD24 controls expansion and persistence of autoreactive T cells in the central nervous system during experimental autoimmune encephalomyelitis. J. Exp. Med. 200:447458.
27 Ge, Q., D. Palliser, H.N. Eisen, and J. Chen. 2002. Homeostatic T cell proliferation in a T cell-dendritic cell coculture system. Proc. Natl. Acad. Sci. USA. 99:29832988.
28 Chu, Y.-W., S.A. Memon, S.O. Sharrow, F.T. Hakim, M. Eckhaus, P.J. Lucas, and R.E. Gress. 2004. Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function. Blood. 104:11101119.
29 Bevan, M.J. 1977. In a radiation chimaera, host H-2 antigens determine immune responsiveness of donor cytotoxic cells. Nature. 269:417418.[CrossRef][Medline]
30 Kay, R., F. Takei, and R.K. Humphries. 1990. Expression cloning of a cDNA encoding M1/69-J11d heat-stable antigens. J. Immunol. 145:19521959.[Abstract]
31 Lutz, M.B., N. Kukutsch, A.L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods. 223:7792.[CrossRef][Medline]
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|